10x Genomics Quote - TXG

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

10.51

Bid

10.50

Ask

10.59

Volume

3,047,660

10.53 Day's Range 11.61

9.27 52 Week Range 40.84

Market Cap

1.285B

Previous Close

11.70

Open

11.525

Last Trade

400

10.51

(formt)

Last Trade Time

Financial Volume

US$ 33,619,911

VWAP

11.0314

Average Volume (3m)

2,553,993

Shares Outstanding

122,301,841

Dividend Yield

PE Ratio

-7.09

Earnings Per Share (EPS)

-1.49

Revenue

610.79M

Net Profit

-182.63M

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics S... 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.10xgenomics.com

Headquarters

Wilmington, Delaware, USA

Founded

10x Genomics Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TXG. The last closing price for 10x Genomics was US$11.70. Over the last year, 10x Genomics shares have traded in a share price range of US$ 9.27 to US$ 40.84.

10x Genomics currently has 122,301,841 shares outstanding. The market capitalization of 10x Genomics is US$1.43 billion. 10x Genomics has a price to earnings ratio (PE ratio) of -7.09.

Form 4 - Statement of changes in beneficial ownership of securities

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products PR Newswire PLEASANTON...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single...

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference PR Newswire PLEASANTON, Calif...

Form S-8 - Securities to be offered to employees in employee benefit plans

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.18	-1.68381665108	10.69	11.79	9.27	4056051	10.88310919	CS
4	-2.92	-21.7423678332	13.43	13.46	9.27	3803803	11.45610701	CS
12	-3.7	-26.0380014075	14.21	17.25	9.27	2553993	13.10505757	CS
26	-11.31	-51.8331805683	21.82	24.38	9.27	2269873	14.91103081	CS
52	-29.21	-73.5397784491	39.72	40.84	9.27	1985168	19.00597835	CS
156	-58.09	-84.6793002915	68.6	83.34	9.27	1446275	33.55936881	CS
260	-55.44	-84.0636846096	65.95	208.99	9.27	1184779	60.40794357	CS

TXG - Frequently Asked Questions (FAQ)

What is the current 10x Genomics share price?

The current share price of 10x Genomics is US$ 10.51

How many 10x Genomics shares are in issue?

10x Genomics has 122,301,841 shares in issue

What is the market cap of 10x Genomics?

The market capitalisation of 10x Genomics is USD 1.43B

What is the 1 year trading range for 10x Genomics share price?

10x Genomics has traded in the range of US$ 9.27 to US$ 40.84 during the past year

What is the PE ratio of 10x Genomics?

The price to earnings ratio of 10x Genomics is -7.09

What is the cash to sales ratio of 10x Genomics?

The cash to sales ratio of 10x Genomics is 2.12

What is the reporting currency for 10x Genomics?

10x Genomics reports financial results in USD

What is the latest annual turnover for 10x Genomics?

The latest annual turnover of 10x Genomics is USD 610.79M

What is the latest annual profit for 10x Genomics?

The latest annual profit of 10x Genomics is USD -182.63M

What is the registered address of 10x Genomics?

The registered address for 10x Genomics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the 10x Genomics website address?

The website address for 10x Genomics is www.10xgenomics.com

Which industry sector does 10x Genomics operate in?

10x Genomics operates in the LAB ANALYTICAL INSTRUMENTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAPSCapstone Holding Corp	US$ 3.11 (1,144.00%)	74.5k
HMRHeidmar Maritime Holdings Corporation	US$ 2.5599 (69.53%)	37.58M
RDFNRedfin Corporation	US$ 9.76 (67.70%)	92.54M
CKPTCheckpoint Therapeutics Inc	US$ 3.9895 (61.52%)	60.92M
STSSSharps Technology Inc	US$ 0.4399 (48.26%)	591.61M
APEDSTKd 100 percent MSTR and 100 percent COIN ETF	US$ 11.591 (-35.98%)	2.58k
SXTCChina SXT Pharmaceuticals Inc	US$ 2.78 (-35.54%)	162.75k
PCLAPicoCELA Inc	US$ 0.8499 (-35.12%)	866.6k
CONLGraniteShares ETF Trust GraniteShares	US$ 15.685 (-34.86%)	8.63M
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF	US$ 19.22 (-32.95%)	24.05M
STSSSharps Technology Inc	US$ 0.4399 (48.26%)	591.61M
NVDANVIDIA Corporation	US$ 106.98 (-5.07%)	364.12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.3701 (-30.86%)	258.67M
TSLATesla Inc	US$ 222.15 (-15.43%)	188.57M
TQQQProShares UltraPro QQQ	US$ 59.81 (-11.27%)	155.18M